[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE154073T1 - Prozess für die herstellung von biologisch aktivem igf-1 durch verwendung von amino-terminal verlängertem igf-1 - Google Patents

Prozess für die herstellung von biologisch aktivem igf-1 durch verwendung von amino-terminal verlängertem igf-1

Info

Publication number
ATE154073T1
ATE154073T1 AT91915251T AT91915251T ATE154073T1 AT E154073 T1 ATE154073 T1 AT E154073T1 AT 91915251 T AT91915251 T AT 91915251T AT 91915251 T AT91915251 T AT 91915251T AT E154073 T1 ATE154073 T1 AT E154073T1
Authority
AT
Austria
Prior art keywords
igf
amino
biologically active
terminal extended
producing biologically
Prior art date
Application number
AT91915251T
Other languages
English (en)
Inventor
Lars Skriver
Kim Ry Hejnas
Henrik Dalboge
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK198990A external-priority patent/DK198990D0/da
Priority claimed from DK249790A external-priority patent/DK249790D0/da
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE154073T1 publication Critical patent/ATE154073T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT91915251T 1990-08-20 1991-08-16 Prozess für die herstellung von biologisch aktivem igf-1 durch verwendung von amino-terminal verlängertem igf-1 ATE154073T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK198990A DK198990D0 (da) 1990-08-20 1990-08-20 Biologisk aktivt polypeptid og fremgangsmaade til omdannelse af dette til et modent protein
DK249790A DK249790D0 (da) 1990-10-16 1990-10-16 Fremgangsmaade til renaturering af et humant protein

Publications (1)

Publication Number Publication Date
ATE154073T1 true ATE154073T1 (de) 1997-06-15

Family

ID=26066263

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91915251T ATE154073T1 (de) 1990-08-20 1991-08-16 Prozess für die herstellung von biologisch aktivem igf-1 durch verwendung von amino-terminal verlängertem igf-1

Country Status (9)

Country Link
US (3) US5459052A (de)
EP (1) EP0545999B1 (de)
JP (1) JPH06500084A (de)
AT (1) ATE154073T1 (de)
AU (1) AU8417091A (de)
DE (1) DE69126434D1 (de)
IE (1) IE912935A1 (de)
PT (1) PT98711B (de)
WO (1) WO1992003477A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4105480A1 (de) * 1991-02-21 1992-08-27 Boehringer Mannheim Gmbh Verbesserte aktivierung von rekombinanten proteinen
US5663304A (en) * 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
US5407810A (en) * 1993-08-20 1995-04-18 Genentech, Inc. Aqueous multiple-phase isolation of polypeptide
US5446024A (en) * 1993-12-17 1995-08-29 Genentech, Inc. Purification of insulin-like growth factor
US6756484B1 (en) * 1995-04-14 2004-06-29 Cephalon, Inc. IGF-I purification process
US5650496A (en) * 1995-04-14 1997-07-22 Cephalon, Inc. IGF-I purification process
DE69731568T2 (de) 1996-01-26 2005-12-22 Eastman Kodak Co. Lichtempfindliche Silberhalogenidemulsionschicht mit gesteigerter photographischer Empfindlichkeit
US5747235A (en) 1996-01-26 1998-05-05 Eastman Kodak Company Silver halide light sensitive emulsion layer having enhanced photographic sensitivity
US5747236A (en) 1996-01-26 1998-05-05 Eastman Kodak Company Silver halide light sensitive emulsion layer having enhanced photographic sensitivity
EP0893731B1 (de) * 1997-07-25 2004-01-28 Eastman Kodak Company Lichtempfindliche Silberhalogenidemulsionsschicht verbesserter photographischer Empfindlichkeit
EP0893732B1 (de) * 1997-07-25 2003-01-22 Eastman Kodak Company Lichtempfindliche Silberhalogenidemulsionsschicht mit verbesserter photographischer Empfindlichkeit
US5994051A (en) * 1997-07-25 1999-11-30 Eastman Kodak Company Silver halide light sensitive emulsion layer having enhanced photographic sensitivity
US6265542B1 (en) * 1997-10-24 2001-07-24 Genentech, Inc. Purification of molecules
US6514682B1 (en) 2001-06-20 2003-02-04 Eastman Kodak Company Speed addendum for photographic emulsions
US20030158593A1 (en) * 2002-02-19 2003-08-21 Heilman Marlin S. Cardiac garment
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
HUE035607T2 (en) 2012-06-25 2018-05-28 Brigham & Womens Hospital Inc Targeted therapeutic agents

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3537708A1 (de) * 1985-10-23 1987-04-23 Boehringer Mannheim Gmbh Verfahren zur aktivierung von t-pa nach expression in prokaryonten
US4766205A (en) * 1985-11-13 1988-08-23 Beatrice Companies, Inc. Method for isolation of recombinant polypeptides in biologically active forms
DE3611817A1 (de) * 1986-04-08 1987-10-15 Boehringer Mannheim Gmbh Verfahren zur renaturierung von proteinen
DE3618817A1 (de) * 1986-06-04 1987-12-10 Behringwerke Ag Verfahren zur gewinnung aktiver proteine aus einer biologisch inaktiven form
IL86090A (en) * 1987-04-16 1993-03-15 Cetus Oncology Corp Production of purified, biologically active, bacterially produced recombinant human csf-1
US4961969A (en) * 1987-05-11 1990-10-09 Cetus Corporation Process for recovering microbially produced interferon-β
WO1988010299A1 (en) 1987-06-24 1988-12-29 Novo-Nordisk A/S A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation
JPH01132598A (ja) * 1987-10-14 1989-05-25 Pitman Moore Inc 変性剤溶液中に含まれる組換え蛋白質における分子内ジスルフィド結合の生成を促進する方法
JP2517100B2 (ja) * 1989-03-08 1996-07-24 協和醗酵工業株式会社 ヒト顆粒球コロニ―刺激因子活性を有する蛋白質の精製法
US5158875A (en) * 1989-08-25 1992-10-27 Amgen Inc. Production of biologically active insulin-like growth factor i from high expression host cell systems

Also Published As

Publication number Publication date
JPH06500084A (ja) 1994-01-06
US5708134A (en) 1998-01-13
PT98711B (pt) 1999-01-29
US5691168A (en) 1997-11-25
PT98711A (pt) 1992-07-31
EP0545999B1 (de) 1997-06-04
EP0545999A1 (de) 1993-06-16
DE69126434D1 (de) 1997-07-10
WO1992003477A1 (en) 1992-03-05
US5459052A (en) 1995-10-17
IE912935A1 (en) 1992-02-26
AU8417091A (en) 1992-03-17

Similar Documents

Publication Publication Date Title
ATE154073T1 (de) Prozess für die herstellung von biologisch aktivem igf-1 durch verwendung von amino-terminal verlängertem igf-1
DK1942189T3 (da) Fremgangsmåde til fremstilling af sekreterede proteiner
ES8504255A1 (es) Procedimiento para la produccion de una hormona de crecimiento de porcino.
ZA929539B (en) Process for producing/secreting a protein by a transformed mould using expression/secretion regulating regions derived from an aspergillus endoxylanase II G
DE69233451D1 (de) Ein verfahren zur herstellung therapeutisch wirksamer bruchstücke von von willebrand-faktor
FI952021A0 (fi) Menetelmä kasvuhormonikiteiden valmistamiseksi ja sillä saadut kiteet
IE872420L (en) Preparing antibiotic a40926 complex
ATE116636T1 (de) Verfahren zur herstellung von 2,6- dichlordiphenylaminessigsäurederivaten.
DE59304218D1 (de) Neues verfahren zur herstellung von beta-carbolinen
EP0280407A3 (de) Verfahren zur Herstellung rekombinanter Polypeptide mit Schweine-Wachstumshormonaktivität
DE58905691D1 (de) Verfahren zur Herstellung von L-alpha-Aminosäuren.
KR100214903B1 (en) Process for producing aminomethanephosphonic acid and aminomethylphosphinic acids
ATE364088T1 (de) Verfahren zur herstellung von pharmazeutisch aktiver, rekombinanter urokinase umfassend die verwendung von buttersäure oder deren salze
DE3883911D1 (de) Verfahren zur Herstellung von Orotsäure durch Fermentierung.
EP0239075A3 (de) Verfahren zur Herstellung eines Fischwachstumshormon-Polypeptids
ATE213234T1 (de) Verfahren zur herstellung von 3-amino-1,2,4- benzotriazindioxide
DE69108192D1 (de) Verfahren zur enzymatischen Herstellung von GRF(1-44)NH2.
FR2741348B1 (fr) Nouveau procede de fabrication du palatinitol
DE3674122D1 (de) Verfahren zur herstellung optisch aktiver alpha-haloalkylarylketone.
ES2045830T3 (es) Procedimiento de preparacion de tensioactivos no ionicos a partir de 1,2-isopropiliden-3-epoxipropil-glicerol y un acido carboxilico.
DE3669151D1 (de) Verfahren zur herstellung von 2-acyl-3,4-alkoxyanilinen.
GR3001086T3 (en) Substituted dioxanones, method for preparing same and use thereof
ES8305326A1 (es) "procedimiento para la preparacion de l-prolina".
ATE25266T1 (de) Verfahren zur biotechnologischen herstellung von l-aepfelsaeure.
SU1083546A1 (ru) СПОСОБ ПОЛУЧЕНИЯ γ-АЦЕТОПРОПИЛОВОГО СПИРТА